Michael Shephard

13 papers receiving 517 citations

Michael Shephard's Hit Papers

Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study 2020 · 199 citations
1990+2+4Years since publication50100150

Peers

Michael Shephard
Comparison fields: 5 of 79
  • Ophthalmology 166
  • Endocrine and Autonomic Systems 40
  • Immunology 107
  • Oncology 129
  • Pediatrics, Perinatology and Child Health 86
Replace Xiaoyan Peng with:
Xiaoyan Peng China
Concettina Gillies United States
Haruo Tamaki Japan
A Balboni Italy
Xiaotong Sun China
K.-M. M�ller Germany
Jonathan Florentin United States
Işık Bökesoy Türkiye
Yasuo Kasubuchi Japan
E. Nakashima Japan
Michael Shephard relative to Xiaoyan Peng China Xiaoyan Peng's profile →
Citations per field
00.5×2×4×6×7.2×
Xiaoyan Peng · 1×
Citations per year

Countries citing papers authored by Michael Shephard

Since Specialization
Citations

This map shows the geographic impact of Michael Shephard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Shephard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Shephard more than expected).

Fields of papers citing papers by Michael Shephard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Shephard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Shephard. The network helps show where Michael Shephard may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Shephard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Shephard Line = papers co-authored together Michael Shephard links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 1963229
2
Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
Hit paper breakdown →
2020199
3 201821
4 200821
5 201919
6 201919
7
Is the spread of non-native plants in Alaska accelerating?
200717
8 199913
9 202011
10 20207
11
Evaluation of Thyroid Function in Health and Disease
20007
12 19643
13 20191

About Michael Shephard

Michael Shephard is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Ecology, Ophthalmology and Organic Chemistry, having authored 13 papers that have together received 567 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (3 papers), Ocular Oncology and Treatments (3 papers), Ubiquitin and proteasome pathways (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Rangeland and Wildlife Management (2 papers), Neonatal Respiratory Health Research (2 papers), Click Chemistry and Applications (1 paper) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Ophthalmology (166 citations), Endocrine and Autonomic Systems (40 citations), Immunology (107 citations), Oncology (129 citations) and Pediatrics, Perinatology and Child Health (86 citations). Michael Shephard has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Robert Usher, John Lind, Sapna P. Patel, Adi Diab, Patrick Hwu, Stephen K. Gruschkus, Meredith Pelster, Dan S. Gombos, Liberty Posada and Roland L. Bassett. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Acta Paediatrica, Obstetrical & Gynecological Survey and Melanoma Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact